Showing results (21-30 of 304) with videos related to

Sort By:
Pageof 31
The Journal of Pathology|November 1, 1995
A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancersJ M Gee, A Douglas-Jones, P Hepburn, et al.
International Journal of Cancer|June 17, 1999
BRCA1 expression levels predict distant metastasis of sporadic breast cancersL T Seery, J M Knowlden, J M Gee, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancerD L Manning, R A McClelland, J M Gee, et al.
International Journal of Cancer|February 13, 1999
Endocrine response and resistance in breast cancer: a role for the transcription factor FosJ M Gee, P C Willsher, F S Kenny, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
The immunohistochemical expression of desmoplakin and its role in vivo in the progression and metastasis of breast cancerE L Davies, J M Gee, R A Cochrane, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancerR A McClelland, J M Gee, A B Francis, et al.
International Journal of Cancer|March 4, 2000
Gamma linolenic acid with tamoxifen as primary therapy in breast cancerF S Kenny, S E Pinder, I O Ellis, et al.
Endocrinology|June 21, 2001
Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex)R A McClelland, D Barrow, T A Madden, et al.
Cancer Research|April 1, 1994
Transforming growth factor-alpha and endocrine sensitivity in breast cancerR I Nicholson, R A McClelland, J M Gee, et al.
International Journal of Cancer|August 22, 1995
Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, I O Ellis, J F Robertson, et al.
Pageof 31